ATAD2 Drives Prostate Cancer Progression to Metastasis

Researchers employed genetically engineered mouse models of prostate cancer bone metastasis, as well as multiple independent human cohorts, to show that ATAD2 was highly enriched in bone metastasis compared to primary tumors.